GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Real estate firm Fathom, which trades publicly on the Nasdaq, is adopting a Bitcoin reserve strategy by buying the ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...

The man behind popular AI bot Truth Terminal sold off a huge chunk of Fartcoin holdings, prompting a price plunge for the ...